Statistics for Hayne Polska Sp. z o.o.

29Total Devices

2Basic UDI-DIs

0Not destined for EU market

0Certificates

0Valid

0Expiring < 6 months

12Countries

Certificate health for Hayne Polska Sp. z o.o.

No certificates registered for this manufacturer.

Devices by risk class

Device catalog for Hayne Polska Sp. z o.o.

Showing 26–29 of 29 devices.

Trade name	Reference / catalog number	UDI-DI code	Quantity	Status
20016501	`20016501`	`05907675536696`	1	On the market
20016401	`20016401`	`05907675536689`	1	On the market
20016301	`20016301`	`00000059005209`	1	On the market
30 szt	`30 szt`	`05907675531097`	1	On the market

1 2

Device families (Basic UDI-DI) of Hayne Polska Sp. z o.o.

Showing 1–2 of 2 device families.

Market presence of Hayne Polska Sp. z o.o.

Devices placed in 12 countries

Poland7
Bulgaria2
Czechia2
Estonia2
EL2
Croatia2
Italy2
Lithuania2
Latvia2
Romania2
Slovenia2
Slovakia2

EUDAMED update: Jan 12, 2026

Hayne Polska Sp. z o.o.

PL-MF-000044330

Active

Address: ul. Jana Henryka Dąbrowskiego, 286/288 60-406 Poznań
Role: Manufacturer
Date of registration: Sep 19, 2024
Country: PL Poland

About Hayne Polska Sp. z o.o.

SRN: PL-MF-000044330
Role: Manufacturer
Country: Poland
Organization name: Hayne Polska Sp. z o.o.
EU VAT number: 7811803630
EORI: PL781180363000000
Trade register: KRS 0000282897
Date of registration: Sep 19, 2024

Contact details for Hayne Polska Sp. z o.o.

Address: 286/288, UL. JANA HENRYKA DĄBROWSKIEGO 60-406 POZNAŃ POLAND
Phone: +48 61 841 02 05
Email: info@hayne.pl
Website: www.hayne.pl

Validator

Name: Urząd Rejestracji Produktów Leczniczych
SRN: PL-CA-014
Phone: +48 22 492 11 71
Email: wm@urpl.gov.pl

Officers and regulatory representatives of Hayne Polska Sp. z o.o.

KOSEK Agnieszka
Ensuring that: (a) the conformity of the devices is appropriately checked, in accordance with the quality management system under which the devices are manufactured, before a device is released; (b) the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; (c) the post-market surveillance obligations are complied with in accordance with Article 10(10); (d) the reporting obligations referred to in Articles 87 to 91 are fulfilled; (e) Not applicable
Hidden

Become a partner of MD Atlas